Results 11 to 20 of about 2,310,131 (142)

CA 19-9 and CA 125 Determination by Immunoluminometric Assay [PDF]

Clinical Chemistry and Laboratory Medicine, 1990
We evaluated a new immunoluminometric technique (ILMA) for the measurement of the cancer antigens, CA 19-9 and CA 125 in serum. A satisfactory reproducibility was found, coefficients of variation ranging from 4.2 to 7.3% in within-run and between-run assays. The linearity of tests was maintained over a wide concentration range. Mean analytical recovery
PLEBANI, MARIO, FAGGIAN, DIEGO, MASIERO, MASSIMO, Giacomini A, Burlina A.   +4 more
openaire   +4 more sources

Yüksek Serum CA19-9 Seviyeleri ile Seyreden Bir Endometriozis Olgusu

Sakarya Tıp Dergisi, 2019
CA19-9 özellikle safra kanalı ve pankreas kanserlerinde yüksek olarak saptanan bir tümör belirtecidir. Bu durumlara ek olarak kolon, mide, over, karaciğer ve özafagus kanserleri gibi diğer malign durumlarda da yüksek seviyelerde saptanır.CA19-9 pankreas ...
Özlem Nuray Sever, Dilahan Şankır
doaj   +1 more source

High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer

Biomedicines, 2020
Background: Non-melanoma skin cancers (NMSC), despite having a favourable prognosis, present an increased risk of occult malignancies. The aim of this study was the evaluation of the usefulness of the mucinous marker carbohydrate 19-9 antigen (CA 19-9 ...
Giulia Malaguarnera, Saverio Latteri, Roberto Madeddu, Vito Emanuele Catania, Gaetano Bertino, Rosario Emanuele Perrotta, Francesco Dinotta, Michele Malaguarnera   +7 more
doaj   +1 more source

Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 patients from the pancreatic cancer cohort in a single institution. [PDF]

PLoS ONE, 2013
BACKGROUND: Life expectancy of pancreatic ductal adenocarcinoma (PDAC) patients is usually short and selection of the most appropriate treatment is crucial.
Joo Kyung Park, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim, Youn Joo Kim, Jaihwan Kim, Byeong Jun Song, Jin Myung Park, Yong Bum Yoon   +8 more
doaj   +1 more source

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

Frontiers in Oncology, 2021
BackgroundWe evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 would
Roman O. Kowalchuk, Scott C. Lester, Rondell P. Graham, William S. Harmsen, Lizhi Zhang, Thorvardur R. Halfdanarson, Rory L. Smoot, Hunter C. Gits, Wen Wee Ma, Dawn Owen, Amit Mahipal, Robert C. Miller, Michelle A. Neben Wittich, Sean P. Cleary, Robert R. McWilliams, Michael G. Haddock, Christopher L. Hallemeier, Mark J. Truty, Kenneth W. Merrell   +18 more
doaj   +1 more source

Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease

Southern Clinics of Istanbul Eurasia, 2019
INTRODUCTION[|]Serum CA 19.9 is commonly used as a tumor marker for diagnosis and follow-up of gastrointestinal malignancies. However, elevated levels can be found in various clinical conditions.[¤]METHODS[|]A total of 285 patients whose serum CA 19.9 ...
Selcuk Şeber, Savaş Güzel, Ahsen Yılmaz, Sonat Pınar Kara, Tarkan Yetisyigit   +4 more
doaj   +1 more source

Metastatc Gastric Adenocarcinoma Cancer With a Very High Serum Carbohydrate Antgen 19-9 Level: A Case Study

Case Reports in Clinical Practice, 2021
Carbohydrate Antigen 19-9 (CA19-9) is a tumor marker for the prognosis of colorectal and pancreatic cancers. The high level of this tumor marker in gastric cancer indicates the advanced stage and peritoneal metastasis of the tumor.
Alireza Jafarinezhad, Neda Aligolighasemabadi   +1 more
doaj   +1 more source

Elevation of CA 125 and CA 19–9 in patients with end-stage liver disease

The International Journal of Biological Markers, 2012
Background The serum tumor markers CA 19–9 and CA 125 are the serologic markers used for the monitoring of biliopancreatic and ovarian cancer, respectively. They are reported to be elevated in a variety of nonneoplastic clinical situations, including end-
Ashish Singhal, Elaine Lander, Andreas Karachristos, Ellen Daly, Phyllis Dowling, Vishal Patel, Manoj Maloo, Ashokkumar Jain MD, FACS   +7 more
doaj   +1 more source

CA 19-9: handle with care

Clinical Chemistry and Laboratory Medicine, 2013
Since its inception in the mid-1980s of the 20th century testing for carbohydrate antigen 19-9 (CA 19-9) has raised expectation for an earlier diagnosis and accurate monitoring of several malignant diseases. After almost 30 years, the available evidences have confirmed the appropriateness and usefulness of determining CA 19-9 levels as a prognostic ...
Galli C, BASSO, DANIELA, PLEBANI, MARIO
openaire   +3 more sources

Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first line therapy.

Frontiers in Oncology, 2013
Background:Serum carbohydrate antigen 19-9 (CA 19-9) has been shown to be a sensitive and specific serum marker for pancreatic cancer. Little has been published about correlations between baseline CA 19-9 level or changes to CA 19-9 level and median ...
Uwe ePelzer, Andreas eHilbig, Jens eStieler, Marianne eSinn, Marcus eBahra, Bernd eDörken, Hanno eRiess   +6 more
doaj   +1 more source